Owlstone Medical

United Kingdom
Cambridge, England, United Kingdom, CB40GD

Company profile

Owlstone Medical company profile

Owlstone Medical focuses on creating breath-based diagnostic tools to enhance early detection of diseases such as cancer and respiratory conditions. The company's Breath Biopsy platform utilizes advanced technology to identify volatile organic compounds in breath, facilitating the discovery of non-invasive biomarkers.

Business identity

Phone number
+4401223428200
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0-$1M
Founded
2004-05-01, Month

Headquarters

Postal code
CB40GD
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
12
Total equity funding
$167.2M
Last funding
Grant / $49.1M / 2025-10-06
Last equity funding
Undisclosed / $2.3M
Investors
9
Lead investors
7
Founders
2
Articles
97

Founders and investors

Founders

Billy BoyleDavid Ruiz Alonso

Lead investors

Advanced Research Projects Agency for HealthAviva VenturesBill & Melinda Gates FoundationCystic Fibrosis FoundationHorizons VenturesMedtekwiz Advisory LtdVentura Capital

Investors

Advanced Research Projects Agency for HealthBill & Melinda Gates FoundationCystic Fibrosis FoundationFoxconn Technology GroupHorizons Ventures